ScoreComparison
Why is Cyclacel Pharmaceuticals, Inc. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.20%
EBIT Growth (5y)
-0.65%
EBIT to Interest (avg)
-18.70
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.13
Sales to Capital Employed (avg)
0.04
Tax Ratio
31.89%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.84%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.69
EV to EBIT
-0.36
EV to EBITDA
-0.36
EV to Capital Employed
-4.79
EV to Sales
4.79
PEG Ratio
NA
Dividend Yield
23.01%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-272.53%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -8.74 MM
NET PROFIT(HY)
Higher at USD -1.4 MM
OPERATING PROFIT(Q)
Highest at USD -1.32 MM
-4What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.02 times
RAW MATERIAL COST(Y)
Grown by 102.04% (YoY
CASH AND EQV(HY)
Lowest at USD 7.73 MM
Here's what is working for Cyclacel Pharmaceuticals, Inc.
Operating Cash Flow
Highest at USD -8.74 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD -1.4 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Profit
At USD -1.4 MM has Grown at 77.45%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Operating Profit
Highest at USD -1.32 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Here's what is not working for Cyclacel Pharmaceuticals, Inc.
Debtors Turnover Ratio
Lowest at 0.02 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Cash and Eqv
Lowest at USD 7.73 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 102.04% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
